@Article{,
AUTHOR = {Iain McAuley, Gary Steinhoff, Michael McNeely, Paul Blood},
TITLE = {Incorrect biochemistry complicates prostate cancer management},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {9},
YEAR = {2002},
NUMBER = {2},
PAGES = {1496--1497},
URL = {http://www.techscience.com/CJU/v9n2/63408},
ISSN = {1488-5581},
ABSTRACT = {A man with a prostate specific antigen (PSA) of 6.1 ng/mL, a clinical stage T2b prostate nodule and biopsies that showed Gleason sum 6 adenocarcinoma of the prostate underwent a radical prostatectomy. The final pathology showed organ-confined disease. His postoperative PSA remained elevated at 4.0 ng/mL. The PSA was repeated several times and was in the same range. It was re-evaluated at another lab facility and was unmeasurable ( <0.02 ng/mL). He has an antibody that cross-reacts with an assay reagent causing this false reading. The most likely antibody is one against mouse immunoglobulin G (IgG). },
DOI = {}
}